Schedule 13G ownership disclosure

VITAE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 92847N103

Event date: 2016-03-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,400,000
Percent of class
12.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-16-006553
Form type
SC 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Mar 28, 2016
Reporting period
Mar 24, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub